Atique U. Ahmed

6.9k citations

100 papers · 5.1k indexed · 1 hit paper · h-index 40

Genetics top 0.5%
- Virus-based gene therapy research 36
- Glioma Diagnosis and Treatment 32
Immunology top 2%
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 9
Oncology top 1%
- CAR-T cell therapy research 17
- Cancer Cells and Metastasis 12
Cancer Research top 2%
Developmental Neuroscience top 2%
Molecular Biology
- RNA Interference and Gene Delivery 29
Biotechnology
- Cancer Research and Treatments 10

Co-authors: Maciej S. Lesniak Brenda Auffinger Alex L. Tobias Yu Han Derek A. Wainwright Irina V. Balyasnikova Lingjiao Zhang Mahua Dey
Cited by: Genetics Immunology Oncology
Partner nations: United States United Kingdom Russia

In The Last Decade

Atique U. Ahmed

95 papers receiving 5.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

Peers

Countries citing papers authored by Atique U. Ahmed

Since Specialization

Citations

This map shows the geographic impact of Atique U. Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atique U. Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atique U. Ahmed more than expected).

Fields of papers citing papers by Atique U. Ahmed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atique U. Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atique U. Ahmed. The network helps show where Atique U. Ahmed may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Atique U. Ahmed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atique U. Ahmed Line = papers co-authored together Atique U. Ahmed links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment Edgar Petrosyan,Jawad Fares,Luis G. Fernandez,Ragini Yeeravalli,Crismita Dmello,Joseph Duffy,Peng Zhang,Catalina Lee-Chang,Jason Miska,Atique U. Ahmed,Adam M. Sonabend,Irina V. Balyasnikova,Amy B. Heimberger,Maciej S. Lesniak	2023	4
2	Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma Wenjing Xuan,Wen-Hao Hsu,Fatima Khan,Madeline Dunterman,Lizhi Pang,Derek A. Wainwright,Atique U. Ahmed,Amy B. Heimberger,Maciej S. Lesniak,Peiwen Chen	2022	80
3	Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts Matthew McCord,Elizabeth T. Bartom,Kirsten B. Burdett,Aneta Baran,Frank Eckerdt,Irina V. Balyasnikova,Kathleen McCortney,Thomas Sears,Shi‐Yuan Cheng,Jann N. Sarkaria,Roger Stupp,Amy B. Heimberger,Atique U. Ahmed,C. David James,Craig Horbinski	2022	11
4	De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma Jack Shireman,Fatemeh Atashi,Gina Lee,Eunüs S. Ali,Miranda R. Saathoff,Cheol H. Park,Sol Savchuk,Shivani Baisiwala,Jason Miska,Maciej S. Lesniak,C. David James,Roger Stupp,Priya Kumthekar,Craig Horbinski,Issam Ben‐Sahra,Atique U. Ahmed	2021	46
5	LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma Shivani Baisiwala,Robert R. Hall,Miranda R. Saathoff,Jack Shireman,Cheol Park,Shreya Budhiraja,Chirag Goel,Louisa Warnke,Clare Hardiman,Jennifer Y. Wang,Kathleen McCortney,Craig Horbinski,Atique U. Ahmed	2020	14
6	Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis Teresa Easwaran,Nicola Lancki,Mario Henriquez,Alexander O. Vortmeyer,Nicholas M. Barbaro,Denise Scholtens,Atique U. Ahmed,Mahua Dey	2020	11
7	CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cellsbreakdown → Alan L. Chang,Jason Miska,Derek A. Wainwright,Mahua Dey,Claudia V. Rivetta,Dou Yu,Deepak Kanojia,Katarzyna C. Pituch,Jian Qiao,Peter Pytel,Yu Han,Meijing Wu,Lingjiao Zhang,Craig Horbinski,Atique U. Ahmed,Maciej S. Lesniak	2016	479
8	Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model Gina Lee,Brenda Auffinger,Donna Guo,Tanwir Hasan,Marc Deheeger,Alex L. Tobias,Jeong Yeon Kim,Fatemeh Atashi,Lingjiao Zhang,Maciej S. Lesniak,C. David James,Atique U. Ahmed	2016	94
9	βIII-Tubulin Regulates Breast Cancer Metastases to the Brain Deepak Kanojia,Ramin A. Morshed,Lingjiao Zhang,Jason Miska,Jian Qiao,Julius W. Kim,Peter Pytel,Irina V. Balyasnikova,Maciej S. Lesniak,Atique U. Ahmed	2015	42
10	Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases Deepak Kanojia,Irina V. Balyasnikova,Ramin A. Morshed,R.T. Frank,Dou Yu,Lingjiao Zhang,Drew Spencer,Julius W. Kim,Yu Han,Dihua Yu,Atique U. Ahmed,Karen S. Aboody,Maciej S. Lesniak	2015	32
11	Therapeutic cell carriers: a potential road to cure glioma Jacob S. Young,Julius W. Kim,Atique U. Ahmed,Maciej S. Lesniak	2014	19
12	Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model Mahua Dey,Alan L. Chang,Derek A. Wainwright,Atique U. Ahmed,Yu Han,Irina V. Balyasnikova,Maciej S. Lesniak	2013	14
13	IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival Derek A. Wainwright,Irina V. Balyasnikova,Alan L. Chang,Atique U. Ahmed,Kyung‐Sub Moon,Brenda Auffinger,Alex L. Tobias,Yu Han,Maciej S. Lesniak	2012	378
14	Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells Sadhak Sengupta,Ilya V. Ulasov,Bart Thaçi,Atique U. Ahmed,Maciej S. Lesniak	2011	11
15	Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model Atique U. Ahmed,Cleo E. Rolle,Matthew A. Tyler,Yu Han,Sadhak Sengupta,Derek A. Wainwright,Irina V. Balyasnikova,Ilya V. Ulasov,Maciej S. Lesniak	2010	58
16	Inhibition of RAS-Mediated Transformation and Tumorigenesis by Targeting the Downstream E3 Ubiquitin Ligase Seven in Absentia Homologue Rebecca L. Schmidt,Cheol Hong Park,Atique U. Ahmed,Justin H. Gundelach,Nanette R. Reed,Cheng Shen,Bruce E. Knudsen,Amy Tang	2007	62
17	The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles Timothy Kottke,Jian Qiao,Rosa María Díaz,Atique U. Ahmed,Benjamin T. Vroman,Jill Thompson,Leonor Sánchez‐Pérez,Richard G. Vile	2006	12
18	A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization Atique U. Ahmed,Jill Thompson,L Emiliusen,Stephen J. Murphy,R. Daniel Beauchamp,Kaori Suzuki,Ramón Alemany,Kevin J. Harrington,Richard G. Vile	2003	35
19	Dendritic Cells for the Immunotherapy of Cancer Alan Melcher,Andrew Bateman,Kevin J. Harrington,Atique U. Ahmed,Michael J. Gough,Richard G. Vile	2002	4
20	A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component L Emiliusen,Michael J. Gough,Adrian C Bateman,Atique U. Ahmed,Richard Voellmy,John Chester,RM Diaz,Kevin J. Harrington,Richard G. Vile	2001	28

About Atique U. Ahmed

Atique U. Ahmed is a scholar working on Genetics, Oncology and Genetics, having authored 100 papers that have together received 5.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (36 papers), Glioma Diagnosis and Treatment (32 papers), RNA Interference and Gene Delivery (29 papers), CAR-T cell therapy research (17 papers), Cancer Cells and Metastasis (12 papers), Immunotherapy and Immune Responses (10 papers), Cancer Research and Treatments (10 papers) and Immune cells in cancer (9 papers). The work is most often cited by research in Genetics (1.4k citations), Immunology (1.4k citations) and Oncology (1.7k citations). Atique U. Ahmed has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Maciej S. Lesniak, Brenda Auffinger, Alex L. Tobias, Yu Han, Derek A. Wainwright, Irina V. Balyasnikova, Lingjiao Zhang, Mahua Dey, Jason Miska and Peter Pytel.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact